• P-ISSN 0973-7200 E-ISSN 2454-8405
  • Follow us

Journal of Pharmaceutical Research

Article

Acute and Subchronic Toxicity and LC-MS Fingerprinting of a Polyherbal Formulation (KNDBHU) used for COVID-19 Management
  • VIEWS 1477
  • PDF 315

Journal of Pharmaceutical Research

DOI: 10.18579/jopcr/v22.1.23.7

Year: 2023, Volume: 22, Issue: 1, Pages: 50-54

Original Article

Acute and Subchronic Toxicity and LC-MS Fingerprinting of a Polyherbal Formulation (KNDBHU) used for COVID-19 Management

Kamal Nayan Dwivedi 1 , Anurag Mishra 1 , Rajesh Kumar Singh​ ✉ 1

 
1 Department of Dravyaguna, Faculty of Ayurveda, Institute of Medical Sciences, Banaras Hindu University, Varanasi­, Uttar Pradesh, 221005, India

Corresponding author : [email protected]



Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Abstract

A polyherbal formulation consisting of Withania somnifera, Tinospora cordifolia, Moringa oleifera, Adhatoda vasica, Pipper longum, Glycyrrhiza glabra, Ocimum sanctum and Curcuma longa has been used for Covid-19 treatment empirically, which was found effective. However, toxicity data were not available for this polyherbal formulation. This study aims to assess the polyherbal formulation's oral acute and subchronic toxicity in rats. The fixed-dose approach was used to conduct the acute toxicity investigation on 6 female Wistar rats for the treatment group and 5 female Wistar rats for the control group. A single dosage of this polyherbal formulation weighing 2,000 mg/kg was administered orally to the test group. At the end of the investigation, no fatalities or major toxic effects were noted, and it was determined that the lethal dose 50% (LD50) of the polyherbal formulation was greater than 2,000 mg/kg. Vital organs underwent macroscopic and microscopic inspection, neither of which revealed any toxicity signs. The polyherbal formulation was given orally for 91 days during the subchronic toxicity research in dose variations: 250 mg/kg, 500 mg/kg, 1,000 mg/kg, 2,000 mg/kg, and 4,000 mg/kg. The daily dose for a human is the same at the lowest level of 250 mg/kg. On physical signs and symptoms, weight growth, food intake, haematological parameters, biochemical parameters, and macroscopic and microscopic examination of organs, no major harmful effects were seen at any of these doses. These results demonstrated that the oral administration of this polyherbal formulation over the short- and long-term is safe when taken as suggested.

Keywords: Ayurvedic, Polyherbal, COVID­19, Acute toxicity, Sub­chronic Oral Toxicity

References

  1. V’kovski P, Kratzel A, Steiner S, Stalder H, Thiel V. Coronavirus biology and replication: implications for SARS-CoV-2. Nature Reviews Microbiology. 2021;19(3):155–170.
  2. Kanchibhotla D, Subramanian S, Kumar RMR, Hari KRV, Pathania MR. An In-vitro evaluation of a polyherbal formulation, against SARS-Cov-2. Journal of Ayurveda and Integrative Medicine. 2022;13(3):100581–100585. Available from: https //doi.org/10.1016/j.jaim.2022.100581
  3. Ben-Shabat S, Yarmolinsky L, Porat D, Dahan A. Antiviral effect of phytochemicals from medicinal plants: Applications and drug delivery strategies. Drug Delivery and Translational Research. 2020;10(2):354–367. Available from: https://doi.org/10.1007/s13346-019-00691-6
  4. Singh M, Jayant K, Singh D, Bhutani S, Poddar NK, Chaudhary AA, et al. Withania somnifera (L.) Dunal (Ashwagandha) for the possible therapeutics and clinical management of SARS-CoV-2 infection: Plant-based drug discovery and targeted therapy. Frontiers in Cellular and Infection Microbiology. 2022;12:01–23. Available from: https://doi.org/10.3389/fcimb.2022.933824
  6. Sreelatha S, Jeyachitra A, Padma PR. Antiproliferation and induction of apoptosis by Moringa oleifera leaf extract on human cancer cells. Food and Chemical Toxicology. 2011;49(6):1270–1275. Available from: https://doi.org/10.1016/j.fct.2011.03.006
  8. Bisht D, Rashid M, Arya RKK, Kumar D, Chaudhary SK, Rana VS, et al. Revisiting liquorice (Glycyrrhiza glabra L.) as anti-inflammatory, antivirals and immunomodulators: Potential pharmacological applications with mechanistic insight. Phytomedicine Plus. 2022;2(1):100206. Available from: https://doi.org/10.1016/j.phyplu.2021.100206
  9. Baliga MS, Jimmy R, Thilakchand KR, Sunitha V, Bhat NR, Saldanha E, et al. Ocimum sanctum L (Holy Basil or Tulsi) and its phytochemicals in the prevention and treatment of cancer. Nutrition and Cancer. 2013;65(sup1):26–35. Available from: https://doi.org/10.1080/01635581.2013.785010
  10. Sharifi-Rad J, Rayess YE, Rizk AA, Sadaka C, Zgheib R, Zam W, et al. Turmeric and Its Major Compound Curcumin on Health: Bioactive Effects and Safety Profiles for Food, Pharmaceutical, Biotechnological and Medicinal Applications. Frontiers in Pharmacology. 2020;11:1–23. Available from: https://doi.org/10.3389%2Ffphar.2020.01021
  11. Xiaohui F, Yi W, Yiyu C. LC/MS fingerprinting of Shenmai injection: A novel approach to quality control of herbal medicines. Journal of Pharmaceutical and Biomedical Analysis. 2006;40(3):591–597. Available from: https://doi.org/10.1016/j.jpba.2005.10.036
  12. Ishtiaq S, Akram M, Kamran SH, Hanif U, Afridi MSK, Sajid-Ur-Rehman, et al. Acute and sub-acute toxicity study of a Pakistani polyherbal formulation. BMC Complementary and Alternative Medicine. 2017;17(1):1–13. Available from: https://doi.org/10.1186/s12906-017-1889-7
  13. Sushruta K, Satyanarayana S, Srinivas S, Sekhar JR. Evaluation of the Blood-Glucose Reducing Effects of Aqueous Extracts of the Selected Umbelliferous Fruits Used in Culinary Practices. Tropical Journal of Pharmaceutical Research. 2007;5(2):613–617. Available from: https://doi.org/10.4314/tjpr.v5i2.14639
  14. Kim SHH, Jun CDD, Suk K, Choi BJ, Lim H, Park S, et al. Gallic Acid Inhibits Histamine Release and Pro-inflammatory Cytokine Production in Mast Cells. Toxicological Sciences. 2006;91(1):123–131. Available from: https://doi.org/10.1093/toxsci/kfj063

Copyright

© 2023 Published by Krupanidhi College of Pharmacy. This is an open-access article under the CC BY-NC-ND license (https://creativecommons.org/licenses/by-nc-nd/4.0/) 

  • 09 May 2023

Year: 2023, Volume: 22, Issue: 1


More articles

DON'T MISS OUT!

Subscribe now for latest articles and news.